Home Other Building Blocks 445490-78-8
445490-78-8,MFCD19382454
Catalog No.:AA00I8D8

445490-78-8 | 1-Boc-7-(2-hydroxyethyl)-3,4-dihydro-1,8-naphthyridine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$422.00   $295.00
- +
1g
95%
in stock  
$912.00   $639.00
- +
5g
95%
in stock  
$2,658.00   $1,861.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00I8D8
Chemical Name:
1-Boc-7-(2-hydroxyethyl)-3,4-dihydro-1,8-naphthyridine
CAS Number:
445490-78-8
Molecular Formula:
C15H22N2O3
Molecular Weight:
278.3468
MDL Number:
MFCD19382454
SMILES:
OCCc1ccc2c(n1)N(CCC2)C(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
341  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  
XLogP3:
1.9  

Downstream Synthesis Route

[1]Miller,WilliamH.;Manley,PeterJ.;Cousins,RussellD.;Erhard,KarlF.;Heerding,DirkA.;Kwon,Chet;Ross,StephenT.;Samanen,JamesM.;Takata,DennisT.;Uzinskas,IreneN.;Yuan,CatherineC.K.;Haltiwanger,R.Curtis;Gress,CatherineJ.;Lark,MichaelW.;Hwang,Shing-Mei;James,IanE.;Rieman,DavidJ.;Willette,RobertN.;Yue,Tian-Li;Azzarano,LeonardM.;Salyers,KevinL.;Smith,BrianR.;Ward,KeithW.;Johanson,KyungO.;Huffman,WilliamF.[BioorganicandMedicinalChemistryLetters,2003,vol.13,#8,p.1483-1486]

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP1218005,2004,B1Locationinpatent:Page22-23

[1]Locationinpatent:schemeortableHarris,CraigS.;Germain,Hervé;Pasquet,Georges[TetrahedronLetters,2008,vol.49,#41,p.5946-5949]

[2]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2003/18064,2003,A1

[3]Miller,WilliamH.;Manley,PeterJ.;Cousins,RussellD.;Erhard,KarlF.;Heerding,DirkA.;Kwon,Chet;Ross,StephenT.;Samanen,JamesM.;Takata,DennisT.;Uzinskas,IreneN.;Yuan,CatherineC.K.;Haltiwanger,R.Curtis;Gress,CatherineJ.;Lark,MichaelW.;Hwang,Shing-Mei;James,IanE.;Rieman,DavidJ.;Willette,RobertN.;Yue,Tian-Li;Azzarano,LeonardM.;Salyers,KevinL.;Smith,BrianR.;Ward,KeithW.;Johanson,KyungO.;Huffman,WilliamF.[BioorganicandMedicinalChemistryLetters,2003,vol.13,#8,p.1483-1486]

[4]Leonard,Kristi;Pan,Wenxi;Anaclerio,Beth;Gushue,JoanM.;Guo,Zihong;DesJarlais,ReneeL.;Chaikin,MargeA.;Lattanze,Jennifer;Crysler,Carl;Manthey,CarlL.;Tomczuk,BruceE.;Marugan,JuanJose[BioorganicandMedicinalChemistryLetters,2005,vol.15,#10,p.2679-2684]

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP1218005,2004,B1Locationinpatent:Page22

[1]Leonard,Kristi;Pan,Wenxi;Anaclerio,Beth;Gushue,JoanM.;Guo,Zihong;DesJarlais,ReneeL.;Chaikin,MargeA.;Lattanze,Jennifer;Crysler,Carl;Manthey,CarlL.;Tomczuk,BruceE.;Marugan,JuanJose[BioorganicandMedicinalChemistryLetters,2005,vol.15,#10,p.2679-2684]

[2]CurrentPatentAssignee:PDRADIOPHARMA-US2016/199520,2016,A1Locationinpatent:Paragraph0275;0288

[3]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-JP2016/183151,2016,ALocationinpatent:Paragraph0310;0311;0324

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2007/141473,2007,A1Locationinpatent:Page/Pagecolumn172-173

[1]Raboisson,Pierre;DesJarlais,ReneeL.;Reed,Rolanda;Lattanze,Jennifer;Chaikin,Margery;Manthey,CarlL.;Tomczuk,BruceE.;Marugan,JuanJose[EuropeanJournalofMedicinalChemistry,2007,vol.42,#3,p.334-343]

[2]CurrentPatentAssignee:T2YC;QINGYAOTONGCHUANGBEIJINGDRUGRESANDDEVELOPMEN-CN113354635,2021,ALocationinpatent:Paragraph0223-0226

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2018/89355,2018,A1Locationinpatent:Page/Pagecolumn87

[4]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2006/108040,2006,A1Locationinpatent:Page/Pagecolumn15

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:445490-78-8 Molecular Formula|445490-78-8 MDL|445490-78-8 SMILES|445490-78-8 1-Boc-7-(2-hydroxyethyl)-3,4-dihydro-1,8-naphthyridine